Global cash-cow income — high yield, lumpy, real. A 4.82% trailing yield from developed-market large caps screened on free cash flow yield and dividend yield and weighted by dividends paid, at a 0.60% expense ratio. The trailing twelve months paid $2.27 a share — $1.0054 in December 2025, then $0.4220, $0.4187 and $0.4281 in the three quarters of 2026 — so the headline yield is real, but it is December-weighted and a single quarter annualised would misstate it badly. The trap check passes comfortably: the price is up about 75% over ten years and total return is about 165% over ten years, so distributions have been paid on top of growth, not carved out of principal.
Key risk: Global value tilt plus lumpiness — the December distribution can dominate the trailing total, the portfolio leans to large-cap value outside the U.S. as well as in it, and the 0.60% fee takes roughly an eighth of the trailing yield before a dollar reaches the holder.
Changes if: Trailing-twelve-month distributions fall for two consecutive quarters, or the expense ratio rises materially. Quarterly lumpiness alone is not a tripwire — the trailing total is.
- ✓Yield check: 4.82% trailing — $2.27 of distributions over the trailing twelve months ($1.0054 in December 2025, $0.4220 in March 2026, $0.4187 in June 2026, $0.4281 in September 2026) at the $47.18 close on October 23, 2026. A high yield for a diversified fund, backed by cash-cow screening rather than leverage or options.
- !Expense check: 0.60% a year is ten times SCHD's 0.06% and consumes roughly an eighth of the trailing yield. The cash-flow and dividend screening is what the extra fee buys — judge whether it is worth it.
- !Distribution-pattern check: Quarterly amounts swing from $0.4187 to $1.0054 because the December payment carries year-end income — the income is real, but a single quarter says almost nothing about the run rate; the $2.27 trailing total is the figure to watch.
- ✓Trap check — distribution vs. total return: Passed — the price is up about 75% over ten years and total return is about 165% over ten years with about 23% over the past year despite roughly 4–5% annual distributions: the distributions were paid on top of growth, not carved out of principal, and no return-of-capital funding was indicated.
What this grade doesn't say: It screens the dividend only — covered, real, compounding. It says nothing about valuation or price: a well-covered payer can still be overpriced, and its price can still fall.